Abstract
In Gram-negative pathogens, β-lactamase production remains the most important contributing factor to β- lactam resistance. β-lactamases are bacterial enzymes that inactivate β-lactam antibiotics by hydrolysis, which results in ineffective compounds. The three major groups usually referred to as the newer β-lactamases are plasmid-mediated AmpC enzymes, extended-spectrum β-lactamases (ESBLs) and carbapenem-hydrolyzing enzymes (including metallo-β- lactamases [MBLs]). Molecular methods that include simple and multiplex PCR, real-time PCR, DNA sequencing and various hybridization-based techniques are used widely in research and reference laboratories for the detection of organisms producing newer β-lactamases. The routine screening in clinical diagnostic laboratories of organisms producing TEM, SHV and OXA types of ESBLs using genotypic methods remains problematic, while the detection of CTX-Ms, plasmid-mediated AmpCs and MBLs shows clinical usefulness. Molecular methods have advantages over phenotypic tests by accurately detecting resistant genes in a rapid fashion and by defining the precise genetic basis of the resistance mechanism providing important information valuable to the early introduction of infection control practices. Molecular assays have the potential to complement conventional phenotypic susceptibility techniques and impact directly on patient care.
Keywords: Molecular assays, detection, extended-spectrum β-lactamases, plasmid-mediated AmpC β-lactamases, metallo-β-lactamases
Current Genomics
Title: Molecular Detection of Bacteria Producing Newer Types of β-Lactamases
Volume: 7 Issue: 3
Author(s): Johann D. D.Pitout
Affiliation:
Keywords: Molecular assays, detection, extended-spectrum β-lactamases, plasmid-mediated AmpC β-lactamases, metallo-β-lactamases
Abstract: In Gram-negative pathogens, β-lactamase production remains the most important contributing factor to β- lactam resistance. β-lactamases are bacterial enzymes that inactivate β-lactam antibiotics by hydrolysis, which results in ineffective compounds. The three major groups usually referred to as the newer β-lactamases are plasmid-mediated AmpC enzymes, extended-spectrum β-lactamases (ESBLs) and carbapenem-hydrolyzing enzymes (including metallo-β- lactamases [MBLs]). Molecular methods that include simple and multiplex PCR, real-time PCR, DNA sequencing and various hybridization-based techniques are used widely in research and reference laboratories for the detection of organisms producing newer β-lactamases. The routine screening in clinical diagnostic laboratories of organisms producing TEM, SHV and OXA types of ESBLs using genotypic methods remains problematic, while the detection of CTX-Ms, plasmid-mediated AmpCs and MBLs shows clinical usefulness. Molecular methods have advantages over phenotypic tests by accurately detecting resistant genes in a rapid fashion and by defining the precise genetic basis of the resistance mechanism providing important information valuable to the early introduction of infection control practices. Molecular assays have the potential to complement conventional phenotypic susceptibility techniques and impact directly on patient care.
Export Options
About this article
Cite this article as:
D.Pitout D. Johann, Molecular Detection of Bacteria Producing Newer Types of β-Lactamases, Current Genomics 2006; 7 (3) . https://dx.doi.org/10.2174/138920206777780238
DOI https://dx.doi.org/10.2174/138920206777780238 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Red Blood Cells as Modulators of T Cell Growth and Survival
Current Pharmaceutical Design Glycolipids as Immune Modulatory Tools
Mini-Reviews in Medicinal Chemistry Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design The Wide Pharmacological Versatility of Semicarbazones, Thiosemicarbazones and Their Metal Complexes
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Polypharmacology in Drug Discovery)
Current Pharmaceutical Design Should We Develop an Inhaled Anti-pneumococcal Vaccine for Adults?
Current Medicinal Chemistry - Anti-Infective Agents Recombinant BCG Vaccine Candidates
Current Molecular Medicine Trends in Diagnosis for Active Tuberculosis Using Nanomaterials
Current Medicinal Chemistry Ascaris lumbricoides: An Overview of Therapeutic Targets
Infectious Disorders - Drug Targets Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer
Current Pharmaceutical Design Curcumin Activates Erythrocyte Membrane Acetylcholinesterase
Letters in Drug Design & Discovery Xanthone: A Promising Antimycobacterial Scaffold
Medicinal Chemistry The Impact of Infection on the Incidence of Autoimmune Disease
Current Topics in Medicinal Chemistry Microwave-Assisted Synthesis, Antimicrobial and Cytotoxic Activities of Some 4-Thioxo-Thiazolidine-2-One Derivatives
Letters in Drug Design & Discovery Anti-Oxidative Stress and Beyond: Multiple Functions of the Protein Glutathionylation
Protein & Peptide Letters Interrelated Roles for the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor-1α in the Immune Response to Infection
Current Immunology Reviews (Discontinued) Nitric Oxide: Friendly Rivalry in Tuberculosis
Current Signal Transduction Therapy Advances in Lipid-Based Subunit Vaccine Formulations
Current Immunology Reviews (Discontinued) Patent Selections
Recent Patents on Anti-Infective Drug Discovery